Digital Media briefs: June 2014

Share this article:
Digital Media briefs: June 2014
Digital Media briefs: June 2014

Patients are using Twitter to discuss adverse events. Becker's Hospital CIO reports that a study found 4,000 adverse events were discussed on Twitter, while only 1,400 were reported to the FDA during the same period. The intensity of the impact varied, and the information was not as detailed as that provided to the FDA, making a one-to-one comparison difficult, but tweets covered OTC and prescription medications.

Camera and lens company Olympus says that its pill-sized camera offers physicians a new perspective. Patients can swallow the FDA-approved device for small-bowel capsule endoscopy procedures. Olympus says the Endocapsule 10 system offers a 160-degree field of vision, 12 hours of battery life and a tracking function that works as a GPS of sorts that shows physicians  the capsule's location in the intestine.

Apple's healthcare push is no rumor. Mobihealth News reports that the Cupertino, CA, company has “snapped up at least half a dozen prominent experts in biomedicine,” with an emphasis on sensor technology. Mobihealth says the company has also poached biomedical engineers from Vital Connect, Masimo Corp and O2 MedTech.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?